AlgoTx
PrivateLast Round
Series B
Mar 14, 2023
Total Funding Raised
$39.17M
Company Overview
AlgoTx operates in Healthcare & Life Sciences and is based in Suresnes. Its latest recorded funding round was a Series B round in March 2023.
AlgoTx is a biotechnology company that develops targeted, first-in-class therapeutics for peripheral neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgoTx Comparables
Compare AlgoTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaNavi Pharma Inc. | 80% | |
| 上海赛默罗生物科技有限公司 | 79% | |
| Pharmaleads | 77% |
For institutional investors. Book with your work email.
AlgoTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2023 | ||||
| Series A | Nov 24, 2020 | ||||
| Grant | Nov 20, 2019 | ||||
| Seed | Jan 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlgoTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Turenne Groupe | Series B |
| Turenne Capital Partenaires | Series B |
| Omnes Capital | Series A, Series B |
| Sofimac Investment Managers | Series B |
| Bpifrance | Grant, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 92% MoM, reaching 1.9K.
- Apr 17, 2026
Monthly visitors increased 284% MoM, reaching 4.5K.
For institutional investors. Book with your work email.
AlgoTx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlgoTx's valuation, stock price, and market status.
Is AlgoTx a public or private company?
AlgoTx is a private company.
What is the current stock price of AlgoTx?
AlgoTx is a private company, so its shares have no public market price. Caplight tracks AlgoTx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlgoTx worth (valuation)?
Valuation information for AlgoTx is not publicly available.
Can I buy AlgoTx stock?
AlgoTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlgoTx's last funding round?
AlgoTx's most recent funding round was Series B on March 14, 2023.
Who are the main investors in AlgoTx?
Key investors in AlgoTx include Turenne Groupe, Turenne Capital Partenaires, Bpifrance.
Will AlgoTx IPO soon?
No public IPO plans have been announced for AlgoTx.
How can I track AlgoTx secondary market activity?
Caplight tracks bids, offers, and trades in AlgoTx's shares on secondary markets.